A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation
This study has been completed.
First Posted: December 16, 2011
Last Update Posted: October 5, 2015
Information provided by (Responsible Party):